The 2026 reemergence of Bundibugyo ebolavirus in eastern Democratic Republic of the Congo has highlighted persistent gaps in outbreak control, with treatment capacity emerging as a critical vulnerability. National situation reporting (SitRep No. 080) documents more than 3,800 confirmed cases and over 1,700 deaths, and indicates that Ebola treatment centers (ETCs) and transit centers are operating well above their official capacities. These operational pressures complicate core response activities such as early case detection, contact tracing, timely isolation and adherence to infection prevention and control (IPC) standards.
Operational indicators cited in the national report show clear evidence of saturation. In North Kivu, bed occupancy was reported at 131.9% (186 patients admitted against 141 official beds) and functional bed-capacity reporting had not changed for seven consecutive surveillance bulletins, limiting situational awareness and resource mobilization. Ituri province, which accounts for roughly 87% of cumulative confirmed cases, has multiple centers exceeding safe operating limits: Nizi ETC at 278%, ISTM Nyakunde at 123%, CME Bunia at 104%, and Lita and Fataki at 100%. Holding areas for suspect cases are similarly overstretched — the Fataki transit center was reported at 200% occupancy.
Overcrowding in isolation units poses both logistical and epidemiological threats. When ETCs exceed capacity, patient separation becomes more difficult, staff workloads rise, and shortages of trained personnel and protective materials are more likely. These conditions undermine IPC adherence and increase the risk of nosocomial amplification, including infections among health care workers. International and national IPC guidance emphasizes the need for sufficient physical separation, appropriate staffing ratios and reliable supplies; structural saturation directly compromises these elements and thereby elevates in-facility transmission risk.
Beyond the risk of nosocomial spread, limited admission capacity delays referral and isolation of suspect cases. These delays extend the period during which infectious individuals remain in households and communities, contributing to higher numbers of community deaths and weakening public trust in the health system. Reduced confidence and access can discourage prompt care-seeking, further increasing community exposure. Moreover, overwhelmed treatment centers strain surveillance operations and contact-tracing teams, hampering rapid secondary-case identification and allowing community transmission chains to persist.
The correspondence frames two interconnected pathways by which ETC overcapacity can sustain Ebola virus transmission. The first is through IPC failures: reduced patient separation, staff shortages and gaps in personal protective equipment increase the likelihood of nosocomial transmission among patients and health care workers. The second pathway is delayed isolation: when admission spaces are maximized, suspect cases wait longer for referral and isolation, which prolongs community infectious periods, increases community deaths and degrades contact-tracing performance. These pathways interact in a self-reinforcing cycle: nosocomial amplification and delayed community isolation both feed continued transmission despite ongoing response efforts.
To break the cycle of overcapacity and sustained transmission, the authors recommend a set of immediate operational measures. Short-term actions proposed in the national report and correspondence include:
Rapid deployment of modular isolation units in the most affected districts to expand safe admission space.
Scale-up of decentralized triage and point-of-care diagnostic capability to accelerate identification and referral of suspected cases.
Re-establishment of transparent daily reporting on usable bed availability to improve situational awareness and guide resource allocation.
Augmentation of IPC supplies and staffing to protect frontline health workers and preserve quality of care within ETCs and transit centers.
The correspondence notes that amplifying these operational capabilities may reduce secondary transmission and strengthen the overall Ebola response.
The authors argue that treatment capacity should be considered not only a clinical resource but an integral epidemiological intervention. Maintaining unstrained ETC capacity preserves IPC standards, supports prompt isolation of suspect cases, maintains surveillance and contact-tracing performance, and sustains public confidence in the response. Without addressing structural saturation of treatment and transit centers, overcrowding may continue to sustain epidemic transmission despite other containment measures.
References cited in the source text include the national SitRep (No. 080), WHO IPC guidance for Ebola and Marburg diseases (2025), and prior reviews of Ebola response and IPC challenges. The source correspondence focuses on operational observations from SitRep No. 080 and synthesizes those findings into the two-pathway framework and recommended short-term actions. Specific quantitative examples of overcapacity given in the source are reproduced above; additional implementation details or outcome data were not reported in the correspondence.